About
Capricor Therapeutics Inc (NASDAQ:CAPR) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
Mar 23 2026
Early Warning Press Release - Frank Guillemette Announces Completion of Acquisition of Common Shares of Caprock Mining Corp.
Mar 12 2026
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 12 2026
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
Mar 10 2026
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
Financials
Revenue
$11.13 M
Market Cap
$1.85 B
EPS
-2.26
Translate